Phoenix Biotech Acquisition Corp.
PBAX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $7,400 | $2,855 | $290,603 | $290,603 |
| - Cash | $2,022 | $3,303 | $5,204 | $3,327 |
| + Debt | $931 | $1,153 | $1,367 | $1,575 |
| Enterprise Value | $6,309 | $705 | $286,766 | $288,852 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$4,363 | -$4,724 | -$4,951 | -$8,210 |
| % Margin | – | – | – | – |
| Net Income | -$11,506 | -$30,118 | -$5,454 | -$8,944 |
| % Margin | – | – | – | – |
| EPS Diluted | -9.1 | -61.71 | -0.11 | -0.18 |
| % Growth | 85.3% | -56,000% | 38.9% | – |
| Operating Cash Flow | -$3,205 | -$4,623 | -$4,446 | -$4,453 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$3,205 | -$4,623 | -$4,446 | -$4,453 |